CNXC vs. ALLE, ULS, MEDP, WPP, HQY, STN, BILI, GLOB, WSC, and ETSY
Should you be buying Concentrix stock or one of its competitors? The main competitors of Concentrix include Allegion (ALLE), UL Solutions (ULS), Medpace (MEDP), WPP (WPP), HealthEquity (HQY), Stantec (STN), Bilibili (BILI), Globant (GLOB), WillScot Mobile Mini (WSC), and Etsy (ETSY). These companies are all part of the "business services" industry.
Concentrix vs.
Allegion (NYSE:ALLE) and Concentrix (NASDAQ:CNXC) are both industrial products companies, but which is the better investment? We will contrast the two businesses based on the strength of their institutional ownership, risk, dividends, profitability, analyst recommendations, media sentiment, earnings, valuation and community ranking.
Allegion has higher earnings, but lower revenue than Concentrix. Concentrix is trading at a lower price-to-earnings ratio than Allegion, indicating that it is currently the more affordable of the two stocks.
Allegion pays an annual dividend of $2.04 per share and has a dividend yield of 1.6%. Concentrix pays an annual dividend of $1.33 per share and has a dividend yield of 3.1%. Allegion pays out 29.9% of its earnings in the form of a dividend. Concentrix pays out 35.8% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Allegion has increased its dividend for 11 consecutive years.
Allegion has a net margin of 15.84% compared to Concentrix's net margin of 2.61%. Allegion's return on equity of 45.12% beat Concentrix's return on equity.
Allegion has a beta of 1.11, meaning that its stock price is 11% more volatile than the S&P 500. Comparatively, Concentrix has a beta of 0.67, meaning that its stock price is 33% less volatile than the S&P 500.
In the previous week, Allegion had 10 more articles in the media than Concentrix. MarketBeat recorded 15 mentions for Allegion and 5 mentions for Concentrix. Concentrix's average media sentiment score of 1.44 beat Allegion's score of 1.04 indicating that Concentrix is being referred to more favorably in the news media.
Allegion currently has a consensus price target of $138.33, suggesting a potential upside of 9.56%. Concentrix has a consensus price target of $75.00, suggesting a potential upside of 74.99%. Given Concentrix's stronger consensus rating and higher possible upside, analysts plainly believe Concentrix is more favorable than Allegion.
Allegion received 410 more outperform votes than Concentrix when rated by MarketBeat users. Likewise, 57.77% of users gave Allegion an outperform vote while only 55.56% of users gave Concentrix an outperform vote.
92.2% of Allegion shares are held by institutional investors. Comparatively, 90.3% of Concentrix shares are held by institutional investors. 0.3% of Allegion shares are held by insiders. Comparatively, 3.2% of Concentrix shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.
Summary
Allegion beats Concentrix on 14 of the 22 factors compared between the two stocks.
Get Concentrix News Delivered to You Automatically
Sign up to receive the latest news and ratings for CNXC and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Concentrix Competitors List
Related Companies and Tools
This page (NASDAQ:CNXC) was last updated on 3/4/2025 by MarketBeat.com Staff
Free CNXC Stock Alerts